-
Six-month countdown to go-live for CTIS
Six-month countdown to go-live for CTIS
-
Six-month countdown to go-live for CTIS
Six-month countdown to go-live for CTIS
The entry into application of the Clinical Trials Regulation and the go-live date for the Clinical Trials Information System (CTIS) will be on 31 January 2022
-
Increased manufacturing capacity for Spikevax
Increased manufacturing capacity for Spikevax
-
Increased manufacturing capacity for Spikevax
Increased manufacturing capacity for Spikevax
EMA’s human medicines committee (CHMP) has approved a scale-up of the active substance production process at Moderna's COVID-19 vaccine manufacturing sites in the United States.
-
CHMP highlights: July 2021
CHMP highlights: July 2021
-
CHMP highlights: July 2021
CHMP highlights: July 2021
EMA’s human medicines committee (CHMP) recommended two medicines for approval at its July 2021 meeting
-
Update on safety of COVID-19 Vaccine Janssen
Update on safety of COVID-19 Vaccine Janssen
-
Update on safety of COVID-19 Vaccine Janssen
Update on safety of COVID-19 Vaccine Janssen
Following an EMA review, Guillain Barré syndrome (GBS) will be listed as a very rare side effect of COVID-19 Vaccine Janssen
